Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct;34(7):e3043.
doi: 10.1002/dmrr.3043. Epub 2018 Jul 17.

Gut microbiome in type 1 diabetes: A comprehensive review

Affiliations
Review

Gut microbiome in type 1 diabetes: A comprehensive review

Peilin Zheng et al. Diabetes Metab Res Rev. 2018 Oct.

Abstract

Type 1 diabetes (T1D) is an autoimmune disease, which is characterized by the destruction of islet β cells in the pancreas triggered by genetic and environmental factors. In past decades, extensive familial and genome-wide association studies have revealed more than 50 risk loci in the genome. However, genetic susceptibility cannot explain the increased incidence of T1D worldwide, which is very likely attributed by the growing impact of environmental factors, especially gut microbiome. Recently, the role of gut microbiome in the pathogenesis of T1D has been uncovered by the increasing evidence from both human subjects and animal models, strongly indicating that gut microbiome might be a pivotal hub of T1D-triggering factors, especially environmental factors. In this review, we summarize the current aetiological and mechanism studies of gut microbiome in T1D. A better understanding of the role of gut microbiome in T1D may provide us with powerful prognostic and therapeutic tools in the near future.

Keywords: environmental factors; genetics; gut microbiome; immune system; type 1 diabetes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The role of gut microbiome in type 1 diabetes. Multiple factors can influence gut microbiome, resulting in an increase in intestinal permeability, a decrease in gut microbiome diversity, and Firmicutes/Bacteroidetes ratio. Consequently, these changes may destroy islet β cells through molecular mimicry, excessive activation of innate immunity, and adaptive immunity

Similar articles

Cited by

References

    1. Boldison J, Wong FS. Immune and pancreatic beta cell interactions in type 1 diabetes. Trends Endocrinol Metab. 2016;27(12):856‐867. - PubMed
    1. Yi B, Huang G, Zhou ZG. Current and future clinical applications of zinc transporter‐8 in type 1 diabetes mellitus. Chin Med J (Engl). 2015;128(17):2387‐2394. - PMC - PubMed
    1. Yang L, Luo S, Huang G, et al. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese. Diabetes Metab Res Rev. 2010;26(7):579‐584. - PMC - PubMed
    1. Chao C, Huang G, Li X, et al. Change of glutamic acid decarboxylase antibody and protein tyrosine phosphatase antibody in Chinese patients with acute‐onset type 1 diabetes mellitus. Chin Med J (Engl). 2013;126(21):4006‐4012. - PubMed
    1. Wang Z, Xie Z, Lu Q, et al. Beyond genetics: what causes type 1 diabetes. Clinic Rev Allerg Immunol. 2016;52(2):273‐584. - PubMed

Publication types

MeSH terms